Israel Englander I Bio, Inc. Transaction History

Millennium Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $502,965 - $350 Million	-2,186,806 Reduced 47.38%	2,428,836 $414,000
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $1.06 Million - $2.12 Million	4,615,642 New	4,615,642 $1.22 Million
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $28,740 - $58,438	-95,801 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $52,690 - $99,633	95,801 New	95,801 $53,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $20,378 - $29,222	-19,225 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $200,220 - $270,789	-164,115 Reduced 89.51%	19,225 $29,000
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $62,039 - $137,749	52,576 Added 40.21%	183,340 $282,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.24 $138,537 - $295,545	-131,940 Reduced 50.22%	130,764 $137,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $237,537 - $895,656	139,728 Added 113.62%	262,704 $533,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $31,255 - $88,377	35,926 Added 41.27%	122,976 $273,000
Q1 2020 May 14, 2020	BUY	$0.22 - $2.45 $19,151 - $213,272	87,050 New	87,050 $92,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.